Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A single fatal case report documenting an unusual dual infection in CGD with a novel genetic mutation; raises clinical awareness but provides no comparative data or interventional evidence.
This is an unreviewed systems engineering paper demonstrating a runtime optimization technique with reported speedup metrics, but lacks clinical or scientific validation, ground-truth comparison, or peer review.
Large real-world retrospective cohort with 4890 patients, adjusted Cox regression analysis, and hard clinical endpoint (overall survival), demonstrating that PSA nadir <0.2 ng/mL predicts OS benefit independent of percentage decline.